Annex D. i+solutions model Long-Term Agreement (LTA) ITB-Iplus/GDF-MED/2023/3
Annex C. List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/3
Annex B. List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/3
ITB document BDQ ITB-Iplus/GDF-MED/2023/3
Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/3
Supplier Information - 2023.07.06 Cepheid Customer information R1 end of service
Q&A ITB-Iplus_GDF-MED_2023_2
Annex K - Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2023/2
Annex J - Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2023/2
Annex I - GMSDs address list ITB-Iplus/GDF-MED/2023/2